Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Ozempic (semaglutide), a GLP-1 receptor agonist licensed for type 2 diabetes treatment in the UK, lists dizziness as an uncommon side effect in the MHRA-approved Summary of Product Characteristics
The doublespeak triggered some backlashnot only because the company is, in fact, capitalizing on the $15 billion weight-loss drug market, but because the company also didnt explicitly mention in the voiceover that it sells the compounded version of these medications (made by combining, mixing, or altering ingredients), which arent approved by the FDA
The medication works by mimicking glucagon-like peptide-1, a natural hormone that controls hunger and satiety
No video visit is required
Clinical trial data showed gallbladder problems affected 1.4% of participants, with all cases occurring in individuals on very low fat diets
US$ 23.13
US$ 27.13
US$ 20.04
US$ 26.78
US$ 26.06
